Topics

Arbutus ends development of AB-506 for hepatitis B http://bit.ly/2Oiye2p  #pharma

20:03 EDT 3 Oct 2019 | FirstWord Pharma

Arbutus ends development of AB-506 for hepatitis B http://bit.ly/2Oiye2p 

Original Article: Arbutus ends development of AB-506 for hepatitis B http://bit.ly/2Oiye2p  #pharma

NEXT ARTICLE

More From BioPortfolio on "Arbutus ends development of AB-506 for hepatitis B http://bit.ly/2Oiye2p  #pharma"

Quick Search

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...